Ergolide

Ergolide

SCHEMBL28262978

C=C1C(=O)O[C@H]2C[C@@H](C)[C@@H]3CCC(=O)[C@@]3(C)[C@@H](OC(C)=O)[C@H]12

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 2/20 0.67
▸ NPC1 O15118 4/20 0.63
▸ MAPT P10636 4/20 0.63
▸ HTT P42858 4/20 0.63
▸ RAB9A P51151 4/20 0.63
▸ MAPK1 P28482 3/20 0.63
▸ AGTR1 P30556 3/20 0.63
▸ GPR55 Q9Y2T6 3/20 0.63
▸ XBP1 P17861 3/20 0.63
▸ MDM2 Q00987 3/20 0.63
▸ PAX8 Q06710 1/20 0.63
▸ POLB P06746 2/20 0.51
▸ THRB P10828 1/20 0.51
▸ OPRK1 P41145 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ BLM P54132 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ TLR9 Q9NR96 1/20 0.51
▸ TERT O14746 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carpesiolin SCHEMBL23601537 0.83 MAPT (0.59) PTGS2NPC1MAPTHTTRAB9A
Carpesiolin SCHEMBL11891059 0.83 MAPT (0.59) PTGS2NPC1MAPTHTTRAB9A
Carpesiolin SCHEMBL21214080 0.83 MAPT (0.59) PTGS2NPC1MAPTHTTRAB9A
Carpesiolin SCHEMBL6425398 0.83 MAPT (0.59) PTGS2NPC1MAPTHTTRAB9A
Carpesiolin SCHEMBL10099626 0.83 MAPT (0.59) PTGS2NPC1MAPTHTTRAB9A
SCHEMBL16639615 0.78 NPC1 (0.62) PTGS2NPC1MAPTHTTRAB9A
Angustibalin SCHEMBL509228 0.77 MAPT (1.00) PTGS2NPC1MAPTHTTRAB9A
Bigelovin SCHEMBL29349709 0.77 MAPT (1.00) PTGS2NPC1MAPTHTTRAB9A
SCHEMBL16641594 0.76 NPC1 (0.60) PTGS2NPC1MAPTHTTRAB9A
SCHEMBL16677163 0.75 NPC1 (0.59) PTGS2NPC1MAPTHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119112731-A Inula helveticus extract and preparation method and application thereof 南京中医药大学 2024-12-13 — — CN claimed
CN-119587535-A Composition containing wampee amide and application thereof in preparation of drugs with liver injury treatment effect 海南医科大学(海南省医学科学院) 2025-03-11 — — CN disclosed
CN-119112731-A Inula helveticus extract and preparation method and application thereof 南京中医药大学 2024-12-13 — — CN disclosed
CN-119112731-A Inula helveticus extract and preparation method and application thereof 南京中医药大学 2024-12-13 — — CN disclosed
CN-109022353-B Bone morphogenetic protein 2 activator and application thereof in promoting osteogenic differentiation of mesenchymal stem cells 山东兴瑞生物科技有限公司 2021-11-02 — — CN disclosed
CN-109022354-B Vascular endothelial growth factor 165 activator and application thereof in stem cells 广东创晟控股集团有限公司 2021-10-01 — — CN disclosed
CN-108913658-B Bone morphogenetic protein 2 activator for inducing stem cell directional differentiation 广东创晟控股集团有限公司 2021-10-01 — — CN disclosed
CN-108913657-B VEGF-165 activator and application thereof in promoting stem cell differentiation 深圳华源再生医学有限公司 2021-07-06 — — CN disclosed
CN-109055307-B BMP-2 activator and application thereof in stem cell induced differentiation 杭州爱唯生命科技有限公司 2021-06-11 — — CN disclosed
CN-109055307-A A kind of BMP-2 activator and the application in terms of stem cell induces differentiation 青海七彩花生物科技有限公司 2018-12-21 — — CN disclosed
CN-109022354-A A kind of vascular endothelial growth factor 165 activator and the application in stem cell 青海七彩花生物科技有限公司 2018-12-18 — — CN disclosed
CN-109022353-A A kind of bone morphogenetic protein 2 activator and the purposes for promoting mescenchymal stem cell Osteoblast Differentiation 青海七彩花生物科技有限公司 2018-12-18 — — CN disclosed
Send feedback